What the French ban of Bt MON810 maize means for science-based risk assessment.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Policy-Led Comparative Environmental Risk Assessment of Genetically Modified Crops: Testing for Increased Risk Rather Than Profiling Phenotypes Leads to Predictable and Transparent Decision-Making.Frontiers in bioengineering and biotechnology · 2018
   Article
2. New GMO regulations for old: Determining a new future for EU crop biotechnology.GM crops & food · 2017
   Review
3. Perspectives on genetically modified crops and food detection.Journal of food and drug analysis · 2016
   Review
4. Public Acceptance of Plant Biotechnology and GM Crops.Viruses · 2015
   Review
5. Public Submissions on the Uganda National Biotechnology and Biosafety Bill, 2012 Reveal Potential Way Forward for Uganda Legislators to Pass the Bill.Frontiers in bioengineering and biotechnology · 2015
   Review
6. Towards a more open debate about values in decision-making on agricultural biotechnology.Transgenic research · 2014
   Article
7. The GMO case in France: politics, lawlessness and postmodernism.GM crops & food · 2014
   Article
8. EFSA's scientific activities and achievements on the risk assessment of genetically modified organisms (GMOs) during its first decade of existence: looking back and ahead.Transgenic research · 2014
   Review
9. Science-based risk assessment requires careful evaluation of all studies.Nature biotechnology · 2013
   Article
10. Society and GMOs--chicken and egg? The lessons from the GM crops debate in Europe over risk management and communication provide valuable pointers for the upcoming debate on GM animals.EMBO reports · 2013
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as